Pennington, NJ, United States of America

Peter C Wade

This inventor holds 54 USPTO granted patents, primarily in Medicinal Chemistry (CPC class 2602). Top assignee: E. R. Squibb Sons, Inc.. Active years: 1976-1986.

USPTO Granted Patents = 54

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 11

Forward Citations = 365(Granted Patents)

Forward Citations (Not Self Cited) = 301(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

54 out of 1,624

E. R. Squibb Sons, Inc.

patents

Years Active: 1976-1986

Loading Chart...

Areas of Expertise:

Benzisothiazole Derivatives

Anti-Inflammatory Compounds

Triazoles

Isoquinoline Diones

Hydrazino Derivatives

Phenylguanidines

Piperidinyl Compounds

Amino Acids

Carbamates

Heterocyclic Compounds

Alkyl Esters

Psychotropic Treatments

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4578474 - Imido, amido and amino derivatives of mercaptoacyl prolines and (1986-03-25),

2. 4497953 - Imido, amido and amino derivatives of mercaptoacyl prolines and (1985-02-05),

3. 4390695 - Imido, amido and amino derivatives of mercaptoacyl prolines and (1983-06-28),

4. 4332812 - Antiinflammatory carbinolamine esters of 1,2,4-triazoles (1982-06-01),

5. 4310461 - Imido, amido and amino derivatives of mercaptoacyl prolines and (1982-01-12),

6. 4293569 - Substituted phenylguanindines and method (1981-10-06),

7. 4242265 - Indolylalkyl esters of mercaptoalkanoic acids (1980-12-30),

8. 4221796 - Substituted imidazolo-pyridines and method (1980-09-09),

9. 4208518 - Substituted hydrazino derivatives of benzisothiazole-1,1-dioxides (1980-06-17),

10. 4198422 - Substituted 2,3-naphthimidazole carbamates and method (1980-04-15),

11. 4180579 - 2-Substituted-1H-benz[de]-isoquinoline-1,3(2H)-diones (1979-12-25),

12. 4178451 - 3-(Substituted hydrazino)benzisothiazole-1,1-dioxides (1979-12-11),

13. 4177191 - 2-Alkyl-3-(substituted hydrazino)benzisothiazolines (1979-12-04),

14. 4174442 - Substituted hydrazino derivatives of benzisothiazole-1,1-dioxides (1979-11-13),

15. 4170651 - 2-Substituted-1H-benz-[de]-isoquinoline-1,3(2H)-diones (1979-10-09),

Title: Innovator Spotlight: Peter C. Wade

Introduction: Peter C. Wade, a prolific inventor based in Pennington, NJ, holds an impressive portfolio of 54 patents. His innovative contributions to the field of pharmaceuticals demonstrate his commitment to advancing medical treatments and improving patient outcomes.

Latest Patents: Among his latest patents are significant inventions involving imido, amido, and amino derivatives of mercaptoacyl prolines. These compounds, alongside pipecolic acids, have been recognized for their potential use in the treatment of hypertension. Wade’s research in this area illustrates his dedication to developing new therapeutic options for managing this prevalent condition.

Career Highlights: Peter C. Wade's career is marked by his association with E.R. Squibb & Sons, Inc., where he has played a vital role in the pharmaceutical research and development landscape. His extensive work in this esteemed company has enabled him to contribute significantly to innovative drug solutions that aim to address critical health issues.

Collaborations: Throughout his career, Wade has collaborated with notable professionals, including B. Richard Vogt and Berthold Richard Vogt. These collaborations highlight the importance of teamwork and shared expertise in driving innovation within the pharmaceutical industry.

Conclusion: Peter C. Wade stands out as an influential figure in the world of patents and pharmaceutical innovations. With a substantial number of patents to his name and a focus on impactful medical treatments, he continues to inspire the next generation of inventors and researchers dedicated to making a difference in healthcare.